STEM

Stock Watchlist 5 January 2015

First off, I am sure some of you have been wondering where I have been. I did not post a watchlist on Friday, and have been off chat/Twitter/StockTwits for the past few days as well. For those of you who do not know, I do not do this full time – I am currently in the Army and have been […]

8:07 am StemCells completes enrollment in spinal cord injury trial; interim data to be presented at upcoming American Spinal Injury Association Conf

moreView todays social media effects on STEMView the latest stocks trending across Twitter. Click to view dashboardSee who StemCells is hiring next, click here to view […]

StemCells’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Martin M. McGlynn Well, thanks Greg. And thanks to everybody for joining us today. So I want to start off by reviewing our accomplishments over the last year, after which Dr. Stephen Huhn, will provide … moreView todays social media effects on STEMView the latest stocks trending across Twitter. Click to view dashboardSee who StemCells is […]

StemCells, Inc. Announces Completion of the First of Two Cohorts in its Dry Age-Related Macular Degeneration Trial

[GlobeNewswire] – NEWARK, Calif. — StemCells, Inc. announced today that it has completed enrollment of the first of two planned patient cohorts in the Company’s clinical trial of its proprietary HuCNS-SC(R) product candidate … moreView todays social media effects on STEMView the latest stocks trending across Twitter. Click to view dashboardSee who StemCells is hiring next, click here to view […]

StemCells, Inc. Adds Byers Eye Institute at Stanford as Second Site for Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration

[at noodls] – NEWARK, Calif., April 18, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) today announced the addition of the Byers Eye Institute at Stanford, located in Palo Alto, Calif., as a second site for … moreView todays social media effects on STEMView the latest stocks trending across Twitter. Click to view dashboardSee who StemCells is hiring next, click here […]

StemCells, Inc. to Participate at 2013 Regen Med Investor Day in New York

[at noodls] – NEWARK, Calif., April 15, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company’s programs and operations at … moreView todays social media effects on STEMView the latest stocks trending across Twitter. Click to view dashboardSee who StemCells is hiring next, click here to view […]

StemCells, Inc. Announces First Patient Cohort Completes Spinal Cord Injury Trial – Gains in Sensory Function Persist 12 Months After Stem Cell Transplant

[at noodls] – Improvement From Complete to Incomplete Injury Observed in One Patient NEWARK, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) today announced that the twelve-month data from the … moreView todays social media effects on STEMView the latest stocks trending across Twitter. Click to view dashboardSee who StemCells is hiring next, click here to view […]

StemCells, Inc. to Present at Phacilitate Cell & Gene Therapy Forum

[at noodls] – NEWARK, Calif., Jan. 23, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) announced today that Ann Tsukamoto, Ph.D., Executive Vice President, Research and Development, will make a presentation on … moreView todays social media effects on STEMView the latest stocks trending across Twitter. Click to view dashboardSee who StemCells is hiring next, click here to view […]

StemCells, Inc. Reports Third Quarter 2012 Financial Results and Provides Business Update

[at noodls] – NEWARK, Calif., Nov. 8, 2012 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based … moreView todays social media effects on STEMView the latest stocks trending across Twitter. Click to view dashboard […]